Search
Rxsight Inc
RXSTAdd to Watchlist
6.260USD
+0.180+2.96%
Close 08-07 16:00（ET）Quotes delayed by 15 min
260.37MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-07The current earnings forecast score of Rxsight Inc is 5.80, ranking 181 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 10.00, with a high of 14.00 and a low of 8.00.
Analyst Rating
Based on
10
analysts
Hold
Current Rating
8.186
Target Price
+34.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Rxsight Inc
RXST
10
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Rxsight Inc's expected revenue for the next quarter?
Rxsight Inc's expected revenue is 27.50M.
What is Rxsight Inc's price target?
Analysts forecast that Rxsight Inc's price target is USD 10.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 8.00.
How have Rxsight IncRXST's recent earnings per share performed?
The market expectation was USD -0.29, while Rxsight IncRXST's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD -0.27.
What is the analyst rating for Rxsight Inc?
Based on the ratings of Rxsight Inc's stock from 10 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.